TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 47 filers reported holding TYRA BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262 | -99.6% | 19 | -99.5% | 0.00% | – |
| Q2 2023 | $70,930 | +10392.6% | 4,165 | +4579.8% | 0.00% | – |
| Q4 2022 | $676 | -66.2% | 89 | -55.5% | 0.00% | – |
| Q3 2022 | $2,000 | -71.4% | 200 | -78.6% | 0.00% | – |
| Q2 2022 | $7,000 | +40.0% | 934 | +103.5% | 0.00% | – |
| Q1 2022 | $5,000 | -88.9% | 459 | -85.5% | 0.00% | – |
| Q4 2021 | $45,000 | +462.5% | 3,165 | +619.3% | 0.00% | – |
| Q3 2021 | $8,000 | – | 440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $31,531,000 | 11.23% |
| Nextech Invest Ltd. | 2,518,582 | $18,008,000 | 6.07% |
| Boxer Capital, LLC | 6,448,359 | $46,106,000 | 2.92% |
| TCG Crossover Management, LLC | 896,418 | $6,409,000 | 2.72% |
| Fairmount Funds Management LLC | 1,416,998 | $10,132,000 | 2.32% |
| RA Capital Management | 7,236,454 | $51,741,000 | 1.38% |
| Frazier Life Sciences Management, L.P. | 1,375,065 | $9,832,000 | 0.93% |
| BVF INC/IL | 2,472,327 | $17,677,000 | 0.85% |
| Sio Capital Management, LLC | 152,159 | $1,088,000 | 0.41% |
| Cormorant Asset Management, LP | 743,988 | $5,320,000 | 0.40% |